Clinical Trial Update: A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia [Phase 1, Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 1/Phase 2 clinical study evaluating IRL790 in patients with Parkinson disease experiencing levodopa-induced dyskin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IRL790

Snippet

Sponsor: Integrative Research Laboratories AB | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED